{"abstract":"This Notice of Proposed Rulemaking (NPRM) proposes to classify the following two steroids as \"anabolic steroids\" under the Controlled Substances Act (CSA): prostanozol (17[beta]-hydroxy- 5[alpha]-androstano[3,2-c]pyrazole) and methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one). The Drug Enforcement Administration (DEA) believes that this action is necessary to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as Schedule III controlled substances subject to the regulatory control provisions of the CSA.","action":"Notice of proposed rulemaking.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2011/11/23/2011-30081.html","cfr_references":[{"chapter":null,"citation_url":null,"part":1300,"title":21}],"citation":"76 FR 72355","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Electronic comments must be submitted and written comments must be postmarked on or before January 23, 2012. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after midnight Eastern Time on the last day of the comment period.","disposition_notes":null,"docket_ids":["Docket No. DEA-341P"],"dockets":[],"document_number":"2011-30081","effective_on":null,"end_page":72362,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2011/11/23/2011-30081.xml","html_url":"https://www.federalregister.gov/documents/2011/11/23/2011-30081/classification-of-two-steroids-prostanozol-and-methasterone-as-schedule-iii-anabolic-steroids-under","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2011-30081?publication_date=2011-11-23","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2011-11-23/2011-30081/mods.xml","not_received_for_publication":null,"page_length":8,"page_views":{"count":1728,"last_updated":"2026-06-17 20:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2011-11-23/pdf/2011-30081.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2011-30081.pdf?1321969836","publication_date":"2011-11-23","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2011/11/23/2011-30081.txt","regulation_id_number_info":{"1117-AB31":{"issue":"201110","html_url":"https://www.federalregister.gov/regulations/1117-AB31/classification-of-two-steroids-prostanozol-and-methasterone-as-schedule-iii-anabolic-steroids-under-","title":"Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201110&RIN=1117-AB31&operation=OPERATION_EXPORT_XML","priority_category":"Substantive, Nonsignificant"}},"regulation_id_numbers":["1117-AB31"],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2011-12-13T08:08:28Z"},"regulations_dot_gov_url":null,"significant":false,"signing_date":null,"start_page":72355,"subtype":null,"title":"Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act","toc_doc":"Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act","toc_subject":null,"topics":["Chemicals","Drug traffic control"],"type":"Proposed Rule","volume":76}